Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase II trial of carboplatin, abraxane, and bevacizumab in NSCLC Heist, R. S., Duda, G. D., Sahani, D., Ancukiewicz, M., Fidias, P., Sequist, L. V., Shaw, A. T., Temel, J. S., Lennes, I. T., Neal, J. W., Pennell, N. A., Lynch, T. J., Engelman, J. A., Jain, R. K. AMER SOC CLINICAL ONCOLOGY. 2011
View details for DOI 10.1200/jco.2011.29.15_suppl.e18016
View details for Web of Science ID 000208880304394